Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Fatigue, Interchange of vaccine products, Periorbital swelling, Pruritus
Clinical narrative: scarring from hives; still has a raised welt on her right cheek; fatigue returned; have the J&J vaccine; Spot on her face, rash on the face; Face hot to the touch; Hives on the right side of her face; swelling under eyes; itching on the face; asthma flare ups; rash on the face; fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives on the right side of her face), PERIORBITAL SWELLING (swelling under eyes), PRURITUS (itching on the face), ASTHMA (asthma flare ups) and RASH (Spot on her face, rash on the face) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 11J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hashimoto's disease and Thyroiditis. Concurrent medical conditions included Asthma.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced FATIGUE (fatigue). On 03-Jan-2021, the patient experienced URTICARIA (Hives on the right side of her face), PERIORBITAL SWELLING (swelling under eyes), PRURITUS (itching on the face), ASTHMA (asthma flare ups) and RASH (rash on the face). On 10-Jan-2021, the patient experienced RASH (Spot on her face, rash on the face) and SKIN WARM (Face hot to the touch). On 09-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (have the J&J vaccine). On an unknown date, the patient experienced SCAR (scarring from hives), URTICARIA (still has a raised welt on her right cheek) and FATIGUE (fatigue returned). The patient was treated with METHYLPREDNISOLONE (MEDROL DOSEPAK) on 03-Jan-2021 at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL PM) on 03-Jan-2021 at an unspecified dose and frequency and LORATADINE (Claritin AM) on 03-Jan-2021 at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives on the right side of her face), PERIORBITAL SWELLING (swelling under eyes), PRURITUS (itching on the face), ASTHMA (asthma flare ups), RASH (Spot on her face, rash on the face), SKIN WARM (Face hot to the touch), SCAR (scarring from hives), RASH (rash on the face), FATIGUE (fatigue returned) and FATIGUE (fatigue) had resolved, INTERCHANGE OF VACCINE PRODUCTS (have the J&J vaccine) outcome was unknown and URTICARIA (still has a raised welt on her right cheek) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No relevant concomitant medications were reported.  The patient on 03JAN2021 the patient had started to experience hives on the right side of her face and swelling under the eyes, rash on the face, itching of the face, and Asthma flares ups. On 03JAN2021 the doctor gave her a Steroid shot, and prescription for Medrol Dose pack, Benadryl PM and Claritin AM. A week later on 10JAN2021 (after finishing Medrol Dose Pack) she had another flare of hives on both sides of the face, Rash on face hot to the touch and Asthma got worst. The doctor told her not to get the second shot. She still had Fatigue and a spot on her face. Patient has never used dermatological fillers.  On 19-APR-2021, the patient reported that she had raised welt on her right cheek (it is not red). She also had some scarring from the hives. Her asthma is now back to baseline. The reaction with her face had resolved. The fatigue occurred right after the shot, went away, when she had the second reaction and went through the second dose of steroids, she had the fatigue return, but the fatigue resolved. She did have the J&J vaccine on 09/APR/2021   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: adverse event and narrative information was updated.